Dysregulation of developmental and cell type-specific expression of glycoconjugates on hematopoietic cells: a new characteristic of myelodysplastic neoplasms (MDS)

Leukemia. 2023 Mar;37(3):702-707. doi: 10.1038/s41375-022-01784-x. Epub 2023 Feb 9.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Glycoconjugates* / metabolism
  • Hematopoietic Stem Cells / metabolism
  • Humans
  • Myelodysplastic Syndromes* / genetics
  • Myelodysplastic Syndromes* / metabolism
  • Neoplasms* / metabolism

Substances

  • Glycoconjugates